Finance

Lists
ANUHPHR:NSE
Anuh Pharma Ltd
₹82,89
-1,00%
(-0,84) 1D
16 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ANUHPHR...
Open
₹84,14
High
₹84,85
Low
₹82,00
Mkt. cap
8,31 mjd
Avg. vol.
223,93 k
Volume
53,34 k
Dividend
1,81%
Quarterly dividend
₹0,37
Ex-dividend date
05 Aug. 2026
P/E ratio
18,82
52-wk high
₹99,50
52-wk low
₹67,00
EPS
₹4,41
No. of employees
323
Open
₹84,14
High
₹84,85
Low
₹82,00
Mkt. cap
8,31 mjd
Avg. vol.
223,93 k
Volume
53,34 k
Dividend
1,81%
Quarterly dividend
₹0,37
Ex-dividend date
05 Aug. 2026
P/E ratio
18,82
52-wk high
₹99,50
52-wk low
₹67,00
EPS
₹4,41
No. of employees
323
News stories
From web sources and news partners
About Anuh Pharma Ltd
CEO-
Employees323
Founded1960
Headquarters-
SectorPharmaceutical industry
Last report
07 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,94 mjd / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,86 mjd
1,97 mjd
2,02 mjd
1,94 mjd
Cost of goods sold
1,45 mjd
1,51 mjd
1,60 mjd
1,48 mjd
Cost of revenue
1,45 mjd
1,51 mjd
1,60 mjd
1,48 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67,46 m
69,11 m
80,08 m
73,52 m
Operating expense
323,32 m
321,02 m
161,01 m
316,47 m
Total operating expenses
1,77 mjd
1,83 mjd
1,76 mjd
1,80 mjd
Operating income
90,18 m
137,98 m
258,68 m
138,55 m
Other non operating income
9,78 m
41,10 m
-84,72 m
30,77 m
EBT including unusual items
99,21 m
178,28 m
155,20 m
169,28 m
EBT excluding unusual items
99,21 m
178,28 m
118,28 m
169,28 m
Income tax expense
23,08 m
43,77 m
38,38 m
55,03 m
Effective tax rate
23,27%
24,55%
24,73%
32,51%
Other operating expenses
227,24 m
221,89 m
52,55 m
218,62 m
Net income
76,12 m
134,51 m
116,81 m
114,25 m
Net profit margin
4,10%
6,82%
5,78%
5,89%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6,60 m
-
Interest expense
-756,00 k
-796,00 k
-1,06 m
-35,00 k
Net interest expenses
-756,00 k
-796,00 k
5,54 m
-35,00 k
Depreciation and amortization charges
28,62 m
30,02 m
28,38 m
24,33 m
EBITDA
117,06 m
158,54 m
285,83 m
165,70 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme